Heidenreich, Paul A <br/><br/>
Cost-effectiveness of chlorthalidone, amlodipine, and lisinopril as first-step treatment for patients with hypertension: an analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).  [electronic resource] 

 -  Journal of general internal medicine  May 2008 
 - 509-16 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1525-1497 
<br/><br/><label>Standard No.: </label>10.1007/s11606-008-0515-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amlodipine--economics<br/>Angiotensin-Converting Enzyme Inhibitors--economics<br/>Calcium Channel Blockers--economics<br/>Chlorthalidone--economics<br/>Cost-Benefit Analysis<br/>Diuretics--economics<br/>Female<br/>Humans<br/>Hypertension--drug therapy<br/>Kaplan-Meier Estimate<br/>Lisinopril--economics<br/>Male<br/>Middle Aged<br/>Myocardial Infarction--prevention & control<br/>Quality-Adjusted Life Years